Drug Type Small molecule drug |
Synonyms ISOT 101, ISOT101 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastroesophageal Reflux | Phase 2 | United States | - | |
| Chronic constipation | Phase 1 | United States | - | |
| Dyspepsia | Phase 1 | United States | - | |
| Irritable bowel syndrome with constipation | Phase 1 | United States | - | |
| Metastatic melanoma | Preclinical | United States | 24 Apr 2024 | |
| Multiple Sclerosis | Preclinical | United States | 24 Apr 2024 |





